NMCC - Profile

:::

羅柏鈞 (Po-Chun Lo)

Return Appointment First Appointment

Lo PC, Ko HK, Chou KT, Hsiao YH, Perng DW, Su KC. A Two-Staged, Risk-Stratified Strategy Combining FEV1/FEV6 and COPD Diagnostic Questionnaire Acts as an Accurate and Cost-Effective COPD Case-Finding Method. Respirology. 2025 Feb 11. (SCI; #First author)
Lo PC, Feng JY, Hsiao YH, Su KC, Chou KT, Chen YM, Ko HK, Perng DW. Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction. Respir Res. 2024 May 15;25(1):209. doi: 10.1186/s12931-024-02830-1. (SCI; #First author)
Hsin YC, Huang YC, Wu YL, Lee SW, Lo PC. From diagnostic biopsy to bullectomy: A case of progressive complications in pulmonary langerhans cell histiocytosis. Respir Med Case Rep. 2025 Jul 19;57:102263. (SCI)
Po-Chun Lo, Chi-Lu Chiang Multiple Nodular Pulmonary Amyloidosis Mimicking Metastatic Lesions: A Case Report , Thorac Med 2022; 37: 120-125
Shen YL, Hsieh YA, Hu PW, Lo PC, Hsiao YH, Ko HK, Lin FC, Huang CW, Su KC, Perng DW. Angiotensin-(1-7) attenuates SARS-CoV2 spike protein-induced interleukin-6 and interleukin-8 production in alveolar epithelial cells through activation of Mas receptor. J Microbiol Immunol Infect. 2023 Dec;56(6):1147-1157. doi: 10.1016/j.jmii.2023.09.003.